State ID
Clinical Trials in Idaho
Idaho is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Idaho and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 41 actively recruiting studies with Idaho sites out of 41 registered in total. The busiest research areas in Idaho are Obesity, Asthma, Advanced Malignant Solid Neoplasm. Leading sponsors running trials in the state include National Cancer Institute (NCI), AstraZeneca, Vertex Pharmaceuticals Incorporated. By stage, Idaho trials break down as Phase 2 (10), Phase 3 (24).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Idaho
Obesity (2)Asthma (1)Advanced Malignant Solid Neoplasm (1)Anatomic Stage III Breast Cancer AJCC v8 (1)Anatomic Stage IV Breast Cancer AJCC v8 (1)Locally Advanced Malignant Solid Neoplasm (1)Malignant Female Reproductive System Neoplasm (1)Metastatic HER2-Negative Breast Carcinoma (1)Metastatic Malignant Solid Neoplasm (1)Recurrent Endometrial Carcinoma (1)Recurrent Fallopian Tube Carcinoma (1)Recurrent Malignant Female Reproductive System Neoplasm (1)
Frequently Asked Questions — Clinical Trials in Idaho
How many clinical trials are currently recruiting in Idaho?
ClinicalMetric currently tracks 41 actively recruiting clinical trials with at least one location in Idaho. The total number of registered studies—including active but not currently enrolling trials—is 41. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Idaho?
Idaho hosts clinical trials across a broad range of medical conditions, including Obesity, Asthma, Advanced Malignant Solid Neoplasm, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Idaho serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Idaho?
To join a clinical trial in Idaho, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Idaho maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Idaho
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT07589608 Phase 2
Recruiting
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone...
Condition
Overweight
Enrollment
400 pts
Location
United States
Sponsor
Eli Lilly and Company
NCT06797518 Phase 2
Recruiting
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kid...
Condition
Glomerulonephritis, IGA
Enrollment
20 pts
Location
United States, Argentina, Israel
Sponsor
Novartis Pharmaceuticals
NCT07437950 Phase 2
Recruiting
Comparing Different Treatment Lengths for Venetoclax in Older People With Newly ...
Condition
Acute Myeloid Leukemia
Enrollment
126 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06888141 N/A
Recruiting
Stress Management for College Students
Condition
Distress, Emotional
Enrollment
500 pts
Location
United States
Sponsor
Boise State University
NCT06422806 Phase 3
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone f...
Condition
Metastatic Dedifferentiated Liposarcoma
Enrollment
365 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06424288 Phase 3
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps Peop...
Condition
Heart Failure
Enrollment
6,712 pts
Location
United States, Argentina, Australia
Sponsor
Boehringer Ingelheim
NCT00736749 N/A
Recruiting
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Gro...
Condition
Hematopoietic Cell Transplantation Recipient
Enrollment
25,000 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
NCT03072927 N/A
Recruiting
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Condition
Lumbar Spinal Stenosis
Enrollment
8,000 pts
Location
United States
Sponsor
Stryker Instruments
NCT06703073 Phase 2
Recruiting
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Condition
Acute Respiratory Distress Syndrome (ARDS)
Enrollment
600 pts
Location
United States
Sponsor
PPD Development, LP
NCT06623422 Phase 3
Recruiting
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
680 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06641466 Phase 3
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used f...
Condition
Menstrual Migraine
Enrollment
723 pts
Location
United States, Argentina, Canada
Sponsor
Pfizer
NCT06524544 Phase 3
Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hzi...
Condition
Locally Advanced Urothelial Carcinoma
Enrollment
320 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT06624670 Phase 3
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyo...
Condition
Pyoderma Gangrenosum
Enrollment
90 pts
Location
United States, Argentina, Australia
Sponsor
LEO Pharma
NCT07538622 N/A
Recruiting
Prospective Post Market Clinical Registry for the Zenflow Spring System - A Mini...
Condition
BPH (Benign Prostatic Hyperplasia)
Enrollment
300 pts
Location
United States
Sponsor
Zenflow, Inc.
NCT06937086 Phase 3
Recruiting
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants W...
Condition
Ulcerative Colitis
Enrollment
350 pts
Location
United States, Austria, Belgium
Sponsor
Eli Lilly and Company
Page 2 of 2 — 41 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology